Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Imagem de Miniatura
Arquivos
art_HOCHMAN_Baseline_Characteristics_and_Risk_Profiles_of_Participants_in_2019.PDF (319.23 KB)
Citações na Scopus
111
Tipo de produção
article
Data de publicação
2019
Editora
AMER MEDICAL ASSOC
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
HOCHMAN, Judith S.
REYNOLDS, Harmony R.
BANGALORE, Sripal
O'BRIEN, Sean M.
ALEXANDER, Karen P.
SENIOR, Roxy
BODEN, William E.
STONE, Gregg W.
GOODMAN, Shaun G.
LOPES, Renato D.
Autor de Grupo de pesquisa
ISCHEMIA Res Grp
Editores
Coordenadores
Organizadores
Citação
JAMA CARDIOLOGY, v.4, n.3, p.273-286, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
IMPORTANCE It is unknown whether coronary revascularization, when added to optimal medical therapy, improves prognosis in patients with stable ischemic heart disease (SIHD) at increased risk of cardiovascular events owing to moderate or severe ischemia. OBJECTIVE To describe baseline characteristics of participants enrolled and randomized in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial and to evaluate whether qualification by stress imaging or nonimaging exercise tolerance test (ETT) influenced risk profiles. DESIGN, SETTING, AND PARTICIPANTS The ISCHEMIA trial recruited patients with SIHD with moderate or severe ischemia on stress testing. Blinded coronary computed tomography angiography was performed in most participants and reviewed by a core laboratory to exclude left main stenosis of at least 50% or no obstructive coronary artery disease (CAD) (< 50% for imaging stress test and < 70% for ETT). The study included 341 enrolling sites (320 randomizing) in 38 countries and patients with SIHD and moderate or severe ischemia on stress testing. Data presented were extracted on December 17, 2018. MAIN OUTCOMES AND MEASURES Enrolled, excluded, and randomized participants' baseline characteristics. No clinical outcomes are reported. RESULTS A total of 8518 patients were enrolled, and 5179 were randomized. Common reasons for exclusion were core laboratory determination of insufficient ischemia, unprotected left main stenosis of at least 50%, or no stenosis that met study obstructive CAD criteria on study coronary computed tomography angiography. Randomized participants had a median age of 64 years, with 1168 women (22.6%), 1726 nonwhite participants (33.7%), 748 Hispanic participants (15.5%), 2122 with diabetes (41.0%), and 4643 with a history of angina (89.7%). Among the 3909 participants randomized after stress imaging, core laboratory assessment of ischemia severity (in 3901 participants) was severe in 1748 (44.8%), moderate in 1600 (41.0%), mild in 317 (8.1%) and none or uninterpretable in 236 (6.0%), Among the 1270 participants who were randomized after nonimaging ETT, core laboratory determination of ischemia severity (in 1266 participants) was severe (an eligibility criterion) in 1051 (83.0%), moderate in 101 (8.0%), mild in 34 (2.7%) and none or uninterpretable in 80 (6.3%). Among the 3912 of 5179 randomized participants who underwent coronary computed tomography angiography, 79.0% had multivessel CAD (n = 2679 of 3390) and 86.8% had left anterior descending (LAD) stenosis (n = 3190 of 3677) (proximal in 46.8% [ n = 1749 of 3739]). Participants undergoing ETT had greater frequency of 3-vessel CAD, LAD, and proximal LAD stenosis than participants undergoing stress imaging. CONCLUSIONS AND RELEVANCE The ISCHEMIA trial randomized an SIHD population with moderate or severe ischemia on stress testing, of whom most had multivessel CAD.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/31657
Referências
  1. Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
  2. Bourque JM, 2015, JACC-CARDIOVASC IMAG, V8, P1309, DOI 10.1016/j.jcmg.2015.09.006
  3. CALIFF RM, 1985, J AM COLL CARDIOL, V5, P1055, DOI 10.1016/S0735-1097(85)80005-X
  4. De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361
  5. Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJM0A0805796
  6. Gaibazzi N, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006202
  7. Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
  8. Hachamovitch R, 2006, J NUCL CARDIOL, V13, P768, DOI 10.1016/j.nuclcard.2006.08.017
  9. Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500
  10. Hachamovitch R, 2009, CIRCULATION, V120, P2197, DOI 10.1161/CIRCULATIONAHA.108.817387
  11. Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973
  12. Mancini GBJ, 2014, JACC-CARDIOVASC INTE, V7, P195, DOI 10.1016/j.jcin.2013.10.017
  13. MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793
  14. Maron DJ, 2018, AM HEART J, V201, P124, DOI 10.1016/j.ahj.2018.04.011
  15. Serruys PW, 2009, EUROINTERVENTION, V5, P50, DOI 10.4244/EIJV5I1A9
  16. Shaw LJ, 2014, JACC-CARDIOVASC IMAG, V7, P593, DOI 10.1016/j.jcmg.2013.10.021
  17. Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
  18. SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9
  19. WEINER DA, 1987, AM J CARDIOL, V60, P262, DOI 10.1016/0002-9149(87)90224-4
  20. WEINER DA, 1984, J AM COLL CARDIOL, V3, P772, DOI 10.1016/S0735-1097(84)80254-5
  21. Yao SS, 2010, J AM SOC ECHOCARDIOG, V23, P832, DOI 10.1016/j.echo.2010.05.004
  22. Zagatina A, 2013, CARDIOL RES, V4, P152, DOI 10.4021/cr294e

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - ODS/03